GlassScriptPhysician profile
Sebastian Brooke
NPI 1770717555
$846.69
in general payments reported to CMS, 2019-2025
8 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $114 · 2021: $172 · 2023: $109 · 2024: $102 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $242.89 | 2021-2023 | Integra, Surgimend, Omnigraft |
| Axogen | $138.02 | 2019 | |
| Depuy Synthes Sales INC. | $114.03 | 2020 | |
| Sientra, INC. | $89.31 | 2019 | |
| Polynovo North America LLC | $84.36 | 2025 | Novosorb Btm |
| Kls-Martin L.P. | $76.64 | 2024 | |
| Novartis Pharmaceuticals Corporation | $52.27 | 2024-2025 | |
| Mentor Worldwide LLC | $49.17 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sebastian Brooke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.